Mackay Shields LLC Grows Stock Holdings in Agilent Technologies Inc (NYSE:A)

Mackay Shields LLC raised its stake in Agilent Technologies Inc (NYSE:A) by 5.2% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 50,567 shares of the medical research company’s stock after buying an additional 2,522 shares during the period. Mackay Shields LLC’s holdings in Agilent Technologies were worth $3,622,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently added to or reduced their stakes in A. Norges Bank purchased a new stake in Agilent Technologies in the 4th quarter valued at about $261,973,000. Parnassus Investments CA raised its holdings in shares of Agilent Technologies by 211.7% in the 1st quarter. Parnassus Investments CA now owns 2,805,671 shares of the medical research company’s stock valued at $200,942,000 after purchasing an additional 1,905,671 shares in the last quarter. Troy Asset Management Ltd bought a new stake in shares of Agilent Technologies in the 4th quarter valued at about $101,748,000. Marshall Wace LLP raised its holdings in shares of Agilent Technologies by 111,608.8% in the 4th quarter. Marshall Wace LLP now owns 1,015,433 shares of the medical research company’s stock valued at $86,627,000 after purchasing an additional 1,014,524 shares in the last quarter. Finally, First Trust Advisors LP raised its holdings in shares of Agilent Technologies by 181.9% in the 1st quarter. First Trust Advisors LP now owns 1,479,846 shares of the medical research company’s stock valued at $105,987,000 after purchasing an additional 954,803 shares in the last quarter.

Several equities research analysts have recently commented on A shares. Royal Bank of Canada started coverage on shares of Agilent Technologies in a report on Tuesday, April 28th. They issued a “sector perform” rating for the company. Citigroup reduced their price target on shares of Agilent Technologies from $85.00 to $75.00 and set a “neutral” rating for the company in a report on Friday, March 20th. Piper Sandler boosted their price target on shares of Agilent Technologies from $86.00 to $96.00 and gave the company an “overweight” rating in a report on Wednesday, February 19th. Stifel Nicolaus reduced their price target on shares of Agilent Technologies from $85.00 to $73.00 and set a “hold” rating for the company in a report on Thursday, April 2nd. Finally, HSBC upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Wednesday, February 12th. Eleven analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Agilent Technologies presently has an average rating of “Hold” and a consensus target price of $80.43.

NYSE:A opened at $80.75 on Friday. The company has a market cap of $25.30 billion, a PE ratio of 33.37 and a beta of 1.10. Agilent Technologies Inc has a twelve month low of $61.13 and a twelve month high of $90.64. The company has a current ratio of 1.64, a quick ratio of 1.27 and a debt-to-equity ratio of 0.37. The company’s 50 day moving average is $77.14 and its two-hundred day moving average is $79.93.

Agilent Technologies (NYSE:A) last released its earnings results on Thursday, May 21st. The medical research company reported $0.71 earnings per share for the quarter, topping the consensus estimate of $0.61 by $0.10. The company had revenue of $1.24 billion for the quarter, compared to the consensus estimate of $1.20 billion. Agilent Technologies had a net margin of 14.59% and a return on equity of 20.49%. Agilent Technologies’s revenue was up .2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.71 EPS. As a group, analysts expect that Agilent Technologies Inc will post 2.95 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Wednesday, April 22nd. Shareholders of record on Tuesday, March 31st were given a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 0.89%. The ex-dividend date was Monday, March 30th. Agilent Technologies’s dividend payout ratio is presently 23.15%.

In other news, CEO Michael R. Mcmullen sold 18,018 shares of the company’s stock in a transaction on Friday, May 8th. The shares were sold at an average price of $80.00, for a total value of $1,441,440.00. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Michael R. Mcmullen sold 8,814 shares of the company’s stock in a transaction on Monday, April 27th. The shares were sold at an average price of $76.20, for a total transaction of $671,626.80. Following the completion of the sale, the chief executive officer now directly owns 542,848 shares in the company, valued at $41,365,017.60. The disclosure for this sale can be found here. In the last three months, insiders have sold 43,929 shares of company stock worth $3,476,727.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Featured Article: How a Strangle Strategy is different from a Straddle Strategy

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.